New study finds high-dose inhaled nitric oxide decreases the risk of death among critically ill Black patients with COVID-19
University of Alabama at BirminghamIn a first-of-its-kind study published in the American Journal of Respiratory and Critical Care Medicine, physician-scientists from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine discovered that high-dose inhaled nitric oxide therapy may improve oxygenation and reduce the risk of mortality among critically ill Black patients with COVID-19.